- Trials with a EudraCT protocol (5,809)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (328)
5,809 result(s) found for: Pharmacokinetics.
Displaying page 1 of 291.
| EudraCT Number: 2012-000737-40 | Sponsor Protocol Number: BAY12-8039/11826 | Start Date*: 2012-02-20 |
| Sponsor Name:Bayer HealthCare Pharmaceuticals | ||
| Full Title: Safety, Tolerability and Pharmacokinetics of Single Dose Intravenous Moxifloxacin in Pediatric Patients | ||
| Medical condition: No medical condition specified as the purpose of this study is to describe the pharmacokinetics of moxifloxacin in children for future antibiotic treatment. | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2016-003785-77 | Sponsor Protocol Number: 59244 | Start Date*: 2017-03-16 |
| Sponsor Name: | ||
| Full Title: Microdosing as a tool to individualize docetaxel dosing: development of a limited sampling model | ||
| Medical condition: Patients with breast-, prostate or non-small cell lung cancer (NSCLC), who are eligible for treatment with docetaxel. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-002230-41 | Sponsor Protocol Number: PPH-LYF02 | Start Date*: 2015-06-29 |
| Sponsor Name:Landspitali University Hospital | ||
| Full Title: Pharmacokinetics of Proton Pump Inhibitors in a random Icelandic Population. | ||
| Medical condition: Gastro Oesophageal Reflux Disease | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: IS (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-002996-34 | Sponsor Protocol Number: PK 2005 xx | Start Date*: 2006-04-27 |
| Sponsor Name:University Hospitals of Leicester NHS Trust | ||
| Full Title: Pharmacokinetics of actinomycin D in children with cancer | ||
| Medical condition: Any children's cancer where this drug is administered as part of the treatment regimen | ||
| Disease: | ||
| Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2016-001894-34 | Sponsor Protocol Number: E7389-A001-113 | Start Date*: 2016-11-16 |
| Sponsor Name:Eisai Inc. | ||
| Full Title: A Phase 1 Study of Eribulin Mesylate (E7389, IND #116,292), a Novel Microtubule Targeting Chemotherapeutic Agent in Children with Refractory or Recurrent Solid Tumors (Excluding CNS), Including Lym... | ||
| Medical condition: Solid Tumors including Lymphomas | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2015-004442-25 | Sponsor Protocol Number: CFAM810B2304 | Start Date*: 2016-04-12 |
| Sponsor Name:Novartis Pharmaceuticals | ||
| Full Title: A multicenter, open-label, single-arm, two-step study to evaluate the safety and single-dose pharmacokinetics of famciclovir and multiple-dose safety after administration of famciclovir oral pediat... | ||
| Medical condition: Chickenpox Herpes Zoster | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2012-000406-29 | Sponsor Protocol Number: Lisette-3 | Start Date*: 2012-07-03 | |||||||||||
| Sponsor Name: | |||||||||||||
| Full Title: The influence of morning versus evening administration on tamoxifen pharmacokinetics | |||||||||||||
| Medical condition: Breast cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2015-002026-39 | Sponsor Protocol Number: N15LDC | Start Date*: 2015-09-10 |
| Sponsor Name:NKI-AVL | ||
| Full Title: The Effect of Prehydration on the Pharmacokinetics of Low-dose Cisplatin | ||
| Medical condition: Tumor | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-004488-30 | Sponsor Protocol Number: TAPAS-PK-2014 | Start Date*: 2014-01-31 |
| Sponsor Name:Haga Hospital | ||
| Full Title: Targeting Antibiotics to Pseudomonas Aeruginosa in Small airways (TAPAS) study in patients with cystic fibrosis: pharmacokinetics (PK) | ||
| Medical condition: Cystic fibrosis | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-007647-14 | Sponsor Protocol Number: Nabu1A2 | Start Date*: 2009-01-07 |
| Sponsor Name:Turku University Hospital | ||
| Full Title: The effect of fluvoxamine and ciprofloxacin on the pharmacokinetics and pharmacodynamics of nabumetone: A three-phase double-blind placebo-controlled cross-over study. | ||
| Medical condition: Pharmacokinetics and pharmacodynamics, healthy volunteer trial | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: FI (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-000131-13 | Sponsor Protocol Number: DDD17CRCCXB1 | Start Date*: 2017-05-11 |
| Sponsor Name:KU Leuven | ||
| Full Title: Pharmacokinetics of Celebrex for the prevention/treatment of colorectal cancer: Systemic pharmacokinetics and elimination of Celebrex in healthy volunteers | ||
| Medical condition: Colorectal cancer | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-003386-18 | Sponsor Protocol Number: ETB | Start Date*: 2013-01-10 |
| Sponsor Name:UMCG | ||
| Full Title: PHARMACOKINETICS AND PHARMACODYNAMICS OF ERTAPENEM IN PATIENTS WITH TUBERCULOSIS | ||
| Medical condition: Tuberculosis | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-007972-70 | Sponsor Protocol Number: 11/2008 FDB | Start Date*: 2009-01-22 |
| Sponsor Name:University Hospital Leuven | ||
| Full Title: Transplacentar pharmacokinetics of remifentanil | ||
| Medical condition: Transplacentar pharmacokinetics of Remifentanil | ||
| Disease: | ||
| Population Age: In utero, Under 18 | Gender: Female | |
| Trial protocol: BE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-003132-12 | Sponsor Protocol Number: s57150 | Start Date*: 2015-11-20 |
| Sponsor Name:UZLeuven | ||
| Full Title: apixaban in end -stage renal disease | ||
| Medical condition: the pharmacokinetics profile of Apixaban allows safe use in patients with end-stage renal disease | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-003114-34 | Sponsor Protocol Number: CUR001 | Start Date*: 2007-11-29 |
| Sponsor Name:Department of Nephrology and Renal Transplantation, University Hospitals Leuven | ||
| Full Title: The impact of oral curcumin (Curcuma longa) on mycophenolic acid and metabolite pharmacokinetics in stable renal allograft recipients: exploratory investigation of the role of intestinal uridine-di... | ||
| Medical condition: Stable renal allograft recipients | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-004207-22 | Sponsor Protocol Number: CLCZ696B2319 | Start Date*: 2017-04-06 | |||||||||||
| Sponsor Name:Novartis Pharma Services AG | |||||||||||||
| Full Title: Multicenter, open-label, study to evaluate safety, tolerability, pharmacokinetics and, pharmacodynamics of LCZ696 followed by a 52-week randomized, double-blind, parallel group, active-controlled s... | |||||||||||||
| Medical condition: Pediatric heart failure 1 month to <18 years old | |||||||||||||
|
|||||||||||||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) FI (Completed) NL (Ongoing) SE (Completed) NO (Completed) ES (Completed) GB (GB - no longer in EU/EEA) CZ (Completed) IT (Completed) FR (Completed) BG (Completed) PL (Completed) HU (Completed) HR (Completed) AT (Completed) PT (Completed) RO (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2015-004443-40 | Sponsor Protocol Number: CFAM810B2305 | Start Date*: 2016-04-12 |
| Sponsor Name:Novartis Pharmaceuticals | ||
| Full Title: A Multicenter, Open-label, Single-arm Study to Evaluate the Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis | ||
| Medical condition: Herpes Labialis | ||
| Disease: | ||
| Population Age: Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2022-000291-19 | Sponsor Protocol Number: COL-ECMO2022 | Start Date*: 2022-06-21 |
| Sponsor Name:Fakultní nemocnice u sv. Anny v Brně | ||
| Full Title: Pharmacokinetics of colistin in critically ill patients with extracorporeal membrane oxygenation | ||
| Medical condition: Pharmacokinetics in critically ill | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: CZ (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-001172-21 | Sponsor Protocol Number: CLO05908 | Start Date*: 2015-05-18 | |||||||||||
| Sponsor Name:Genzyme Japan K.K. | |||||||||||||
| Full Title: A Phase 1, Open-label, Multi-center Study of Clofarabine in Japanese Pediatric Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia | |||||||||||||
| Medical condition: Acute Lymphoblastic Leukemia | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: Outside EU/EEA | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2012-001632-64 | Sponsor Protocol Number: CLCZ696B2225 | Start Date*: 2012-08-08 | |||||||||||
| Sponsor Name:Novartis Pharma Services AG | |||||||||||||
| Full Title: An open label, three-period, single sequence study to evaluate the pharmacokinetic drug-drug interaction between LCZ696 and sildenafil in subjects with mild to moderate hypertension | |||||||||||||
| Medical condition: mild to moderate hypertension | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
